(Q37208972)

19 August 2017

1 reference

title

Neuro-ophthalmic complications in giant cell arteritis (English)

1 reference

19 August 2017

Frances A Borg

1

1 reference

19 August 2017

Victoria L J Salter

series ordinal

2

1 reference

19 August 2017

Bhaskar Dasgupta

series ordinal

3

1 reference

19 August 2017

publication date

1 July 2008

1 reference

Current Allergy and Asthma Reports

19 August 2017

published in

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

323-330

1 reference

Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11882-008-0052-4

Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis

21 January 2018

1 reference

12 December 2020

Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients

1 reference

12 December 2020

Orbital presentations of giant cell arteritis

1 reference

12 December 2020

Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.

1 reference

12 December 2020

Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis

1 reference

12 December 2020

Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.

1 reference

12 December 2020

Disease patterns and tissue cytokine profiles in giant cell arteritis

1 reference

12 December 2020

Does this patient have temporal arteritis?

1 reference

12 December 2020

Slowly progressive vision loss in giant cell arteritis

1 reference

12 December 2020

Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.

1 reference

12 December 2020

A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

1 reference

12 December 2020

Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes

1 reference

12 December 2020

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial

1 reference

12 December 2020

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial

1 reference

12 December 2020

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study

1 reference

12 December 2020

The epidemiology of giant cell arteritis : a 12-year retrospective study

1 reference

12 December 2020

Diagnostic value of high-resolution MR imaging in giant cell arteritis

1 reference

12 December 2020

Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis

1 reference

12 December 2020

Risk factors for early visual deterioration in temporal arteritis.

1 reference

12 December 2020

How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?

1 reference

12 December 2020

The use of ultrasound as an aid in the diagnosis of giant cell arteritis: a pilot study comparing histological features with ultrasound findings

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

1 reference

12 December 2020

Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis

1 reference

12 December 2020

Temporal artery biopsy: is there any value in examining biopsies at multiple levels?

1 reference

12 December 2020

Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis?

1 reference

12 December 2020

Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis

1 reference

12 December 2020

Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.

1 reference

12 December 2020

Poor prognosis of visual outcome after visual loss from giant cell arteritis

1 reference

12 December 2020

Therapeutic effects of acetylsalicylic acid in giant cell arteritis

1 reference

12 December 2020

Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy

1 reference

12 December 2020

Successful treatment of resistant giant cell arteritis with etanercept

1 reference

12 December 2020

Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

1 reference

12 December 2020

Utility values associated with blindness in an adult population

1 reference

12 December 2020

Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment.

1 reference

12 December 2020

A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.

1 reference

12 December 2020

Risk factors for cranial ischemic complications in giant cell arteritis

1 reference

12 December 2020

Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?

1 reference

12 December 2020

Experience with infliximab (anti-TNF monoclonal antibody) as monotherapy for giant cell arteritis

1 reference

12 December 2020

Color duplex ultrasonography in the diagnosis of temporal arteritis

1 reference

12 December 2020

Meta-analysis: test performance of ultrasonography for giant-cell arteritis

1 reference

12 December 2020

Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients

1 reference

12 December 2020

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects

1 reference

12 December 2020

Bilateral choroidal ischemia in giant cell arteritis

1 reference

12 December 2020

Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis

1 reference

12 December 2020

Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis

1 reference

12 December 2020

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

1 reference

12 December 2020

Arterial wall injury in giant cell arteritis

1 reference

12 December 2020

Recovery of visual function in patients with biopsy-proven giant cell arteritis

1 reference

12 December 2020

Treatment of longstanding active giant cell arteritis with infliximab: report of four cases

1 reference

12 December 2020

Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial

1 reference

12 December 2020

Low diagnostic yield with second biopsies in suspected giant cell arteritis

1 reference

12 December 2020

Steroid management in giant cell arteritis

1 reference

12 December 2020

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis

1 reference

12 December 2020

10.1007/S11882-008-0052-4

Identifiers

DOI

1 reference

19 August 2017

1 reference